

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of water loss via skin (GO:0033561) | 9.25207635 |
| 2 | hair follicle morphogenesis (GO:0031069) | 9.12009814 |
| 3 | linoleic acid metabolic process (GO:0043651) | 8.72263524 |
| 4 | intermediate filament cytoskeleton organization (GO:0045104) | 8.10507590 |
| 5 | intermediate filament-based process (GO:0045103) | 7.86376305 |
| 6 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 7.85757751 |
| 7 | very long-chain fatty acid metabolic process (GO:0000038) | 7.54166855 |
| 8 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 7.47647340 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.41657278 |
| 10 | L-phenylalanine catabolic process (GO:0006559) | 7.41657278 |
| 11 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 7.11721425 |
| 12 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.10522828 |
| 13 | L-phenylalanine metabolic process (GO:0006558) | 7.10522828 |
| 14 | aromatic amino acid family catabolic process (GO:0009074) | 6.77077499 |
| 15 | peptide cross-linking (GO:0018149) | 6.74969607 |
| 16 | epidermis development (GO:0008544) | 6.39584497 |
| 17 | multicellular organismal water homeostasis (GO:0050891) | 6.25808607 |
| 18 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.22393444 |
| 19 | tryptophan catabolic process (GO:0006569) | 6.22093736 |
| 20 | indole-containing compound catabolic process (GO:0042436) | 6.22093736 |
| 21 | indolalkylamine catabolic process (GO:0046218) | 6.22093736 |
| 22 | keratinocyte proliferation (GO:0043616) | 6.15163582 |
| 23 | fatty-acyl-CoA metabolic process (GO:0035337) | 6.05817613 |
| 24 | kynurenine metabolic process (GO:0070189) | 5.99037134 |
| 25 | acyl-CoA biosynthetic process (GO:0071616) | 5.93615516 |
| 26 | thioester biosynthetic process (GO:0035384) | 5.93615516 |
| 27 | glyoxylate metabolic process (GO:0046487) | 5.89751340 |
| 28 | retinol metabolic process (GO:0042572) | 5.87965915 |
| 29 | tryptophan metabolic process (GO:0006568) | 5.86148507 |
| 30 | keratinocyte differentiation (GO:0030216) | 5.83466466 |
| 31 | bile acid biosynthetic process (GO:0006699) | 5.79683897 |
| 32 | alpha-linolenic acid metabolic process (GO:0036109) | 5.53500746 |
| 33 | cysteine metabolic process (GO:0006534) | 5.52457466 |
| 34 | urea cycle (GO:0000050) | 5.44265827 |
| 35 | urea metabolic process (GO:0019627) | 5.44265827 |
| 36 | positive regulation of chemokine secretion (GO:0090197) | 5.37968760 |
| 37 | high-density lipoprotein particle remodeling (GO:0034375) | 5.37403513 |
| 38 | hair cycle process (GO:0022405) | 5.35677973 |
| 39 | molting cycle process (GO:0022404) | 5.35677973 |
| 40 | serine family amino acid catabolic process (GO:0009071) | 5.29032401 |
| 41 | negative regulation of fibrinolysis (GO:0051918) | 5.28357746 |
| 42 | sulfur amino acid catabolic process (GO:0000098) | 5.26528078 |
| 43 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.18370269 |
| 44 | protein carboxylation (GO:0018214) | 5.18370269 |
| 45 | water homeostasis (GO:0030104) | 5.18166073 |
| 46 | regulation of fibrinolysis (GO:0051917) | 5.08470363 |
| 47 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.04952788 |
| 48 | bile acid metabolic process (GO:0008206) | 5.02744308 |
| 49 | nitrogen cycle metabolic process (GO:0071941) | 5.01093272 |
| 50 | positive regulation of keratinocyte differentiation (GO:0045618) | 5.00620597 |
| 51 | complement activation, alternative pathway (GO:0006957) | 4.98130726 |
| 52 | long-chain fatty acid biosynthetic process (GO:0042759) | 4.97934314 |
| 53 | regulation of protein activation cascade (GO:2000257) | 4.96960196 |
| 54 | aromatic amino acid family metabolic process (GO:0009072) | 4.92601208 |
| 55 | homocysteine metabolic process (GO:0050667) | 4.89465735 |
| 56 | lysine catabolic process (GO:0006554) | 4.89344879 |
| 57 | lysine metabolic process (GO:0006553) | 4.89344879 |
| 58 | regulation of chemokine secretion (GO:0090196) | 4.87418092 |
| 59 | epidermal cell differentiation (GO:0009913) | 4.87371237 |
| 60 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 4.80314876 |
| 61 | amino-acid betaine metabolic process (GO:0006577) | 4.76930749 |
| 62 | reverse cholesterol transport (GO:0043691) | 4.71919811 |
| 63 | regulation of cholesterol esterification (GO:0010872) | 4.71601428 |
| 64 | alpha-amino acid catabolic process (GO:1901606) | 4.68696221 |
| 65 | regulation of triglyceride catabolic process (GO:0010896) | 4.63583354 |
| 66 | tyrosine metabolic process (GO:0006570) | 4.63064269 |
| 67 | regulation of complement activation (GO:0030449) | 4.62189067 |
| 68 | cellular ketone body metabolic process (GO:0046950) | 4.60839842 |
| 69 | protein-lipid complex remodeling (GO:0034368) | 4.59399470 |
| 70 | macromolecular complex remodeling (GO:0034367) | 4.59399470 |
| 71 | plasma lipoprotein particle remodeling (GO:0034369) | 4.59399470 |
| 72 | acylglycerol homeostasis (GO:0055090) | 4.53159602 |
| 73 | triglyceride homeostasis (GO:0070328) | 4.53159602 |
| 74 | negative regulation of sterol transport (GO:0032372) | 4.51306069 |
| 75 | negative regulation of cholesterol transport (GO:0032375) | 4.51306069 |
| 76 | lipoxygenase pathway (GO:0019372) | 4.48754561 |
| 77 | cellular glucuronidation (GO:0052695) | 4.47323170 |
| 78 | phospholipid efflux (GO:0033700) | 4.47052354 |
| 79 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 4.42243690 |
| 80 | indolalkylamine metabolic process (GO:0006586) | 4.41081225 |
| 81 | glycine metabolic process (GO:0006544) | 4.38040846 |
| 82 | bile acid and bile salt transport (GO:0015721) | 4.36435326 |
| 83 | cellular biogenic amine catabolic process (GO:0042402) | 4.35132774 |
| 84 | amine catabolic process (GO:0009310) | 4.35132774 |
| 85 | primary alcohol metabolic process (GO:0034308) | 4.34752679 |
| 86 | cellular amino acid catabolic process (GO:0009063) | 4.33480168 |
| 87 | coenzyme catabolic process (GO:0009109) | 4.31761867 |
| 88 | drug catabolic process (GO:0042737) | 4.30861807 |
| 89 | serine family amino acid metabolic process (GO:0009069) | 4.30520677 |
| 90 | imidazole-containing compound metabolic process (GO:0052803) | 4.27152887 |
| 91 | glutamate metabolic process (GO:0006536) | 4.26605890 |
| 92 | plasma lipoprotein particle clearance (GO:0034381) | 4.22127341 |
| 93 | hemidesmosome assembly (GO:0031581) | 4.19277995 |
| 94 | cellular modified amino acid catabolic process (GO:0042219) | 4.19099667 |
| 95 | triglyceride biosynthetic process (GO:0019432) | 4.18649163 |
| 96 | ethanol oxidation (GO:0006069) | 4.15034517 |
| 97 | benzene-containing compound metabolic process (GO:0042537) | 4.14928386 |
| 98 | serine family amino acid biosynthetic process (GO:0009070) | 4.10728372 |
| 99 | cholesterol efflux (GO:0033344) | 4.06519335 |
| 100 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.05186808 |
| 101 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.02733119 |
| 102 | regulation of keratinocyte differentiation (GO:0045616) | 4.00438841 |
| 103 | uronic acid metabolic process (GO:0006063) | 4.00276513 |
| 104 | glucuronate metabolic process (GO:0019585) | 4.00276513 |
| 105 | short-chain fatty acid metabolic process (GO:0046459) | 3.98253146 |
| 106 | ketone body metabolic process (GO:1902224) | 3.98193535 |
| 107 | neutral lipid biosynthetic process (GO:0046460) | 3.95124250 |
| 108 | acylglycerol biosynthetic process (GO:0046463) | 3.95124250 |
| 109 | low-density lipoprotein particle remodeling (GO:0034374) | 3.94886349 |
| 110 | aldehyde catabolic process (GO:0046185) | 3.92067777 |
| 111 | arginine metabolic process (GO:0006525) | 3.92010582 |
| 112 | regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358) | 3.90284288 |
| 113 | plasma lipoprotein particle assembly (GO:0034377) | 3.88711712 |
| 114 | drug transmembrane transport (GO:0006855) | 3.86883650 |
| 115 | urate metabolic process (GO:0046415) | 3.86517475 |
| 116 | carboxylic acid catabolic process (GO:0046395) | 3.83064958 |
| 117 | organic acid catabolic process (GO:0016054) | 3.83064958 |
| 118 | regulation of bile acid biosynthetic process (GO:0070857) | 3.79634828 |
| 119 | positive regulation of epidermal cell differentiation (GO:0045606) | 3.79557253 |
| 120 | fibrinolysis (GO:0042730) | 3.77650321 |
| 121 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.73739255 |
| 122 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.73739255 |
| 123 | flavonoid metabolic process (GO:0009812) | 3.73735208 |
| 124 | regulation of sequestering of triglyceride (GO:0010889) | 3.72364833 |
| 125 | acetyl-CoA metabolic process (GO:0006084) | 3.71594854 |
| 126 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.71243657 |
| 127 | regulation of cholesterol homeostasis (GO:2000188) | 3.70635879 |
| 128 | phospholipid homeostasis (GO:0055091) | 3.69452528 |
| 129 | cholesterol homeostasis (GO:0042632) | 3.67830716 |
| 130 | exogenous drug catabolic process (GO:0042738) | 3.67413471 |
| 131 | cofactor catabolic process (GO:0051187) | 3.65765971 |
| 132 | positive regulation of lipid catabolic process (GO:0050996) | 3.63101382 |
| 133 | sterol homeostasis (GO:0055092) | 3.62673664 |
| 134 | aspartate family amino acid catabolic process (GO:0009068) | 3.61325053 |
| 135 | blood coagulation, intrinsic pathway (GO:0007597) | 3.59841034 |
| 136 | negative regulation of lipase activity (GO:0060192) | 3.57858546 |
| 137 | NAD biosynthetic process (GO:0009435) | 3.57033630 |
| 138 | monocarboxylic acid catabolic process (GO:0072329) | 3.55956409 |
| 139 | one-carbon compound transport (GO:0019755) | 3.55626412 |
| 140 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.55246372 |
| 141 | acyl-CoA metabolic process (GO:0006637) | 3.54602953 |
| 142 | thioester metabolic process (GO:0035383) | 3.54602953 |
| 143 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 3.54193769 |
| 144 | response to phenylpropanoid (GO:0080184) | 3.50208254 |
| 145 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 3.40539125 |
| 146 | defense response to fungus (GO:0050832) | 3.33861551 |
| 147 | carnitine metabolic process (GO:0009437) | 3.32942776 |
| 148 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.31627566 |
| 149 | disruption of cells of other organism (GO:0044364) | 3.21822817 |
| 150 | killing of cells of other organism (GO:0031640) | 3.21822817 |
| 151 | positive regulation of epidermis development (GO:0045684) | 3.14268563 |
| 152 | primary alcohol catabolic process (GO:0034310) | 3.13920762 |
| 153 | phosphatidylcholine acyl-chain remodeling (GO:0036151) | 3.10452767 |
| 154 | epithelium development (GO:0060429) | 3.05800293 |
| 155 | hair cycle (GO:0042633) | 25.7895410 |
| 156 | molting cycle (GO:0042303) | 25.7895410 |
| 157 | skin morphogenesis (GO:0043589) | 2.97265372 |
| 158 | regulation of phospholipase A2 activity (GO:0032429) | 2.95193833 |
| 159 | adhesion of symbiont to host cell (GO:0044650) | 2.95041610 |
| 160 | virion attachment to host cell (GO:0019062) | 2.95041610 |
| 161 | phosphatidylserine metabolic process (GO:0006658) | 2.92622571 |
| 162 | unsaturated fatty acid biosynthetic process (GO:0006636) | 2.91790329 |
| 163 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.91652649 |
| 164 | fatty acid biosynthetic process (GO:0006633) | 2.91095555 |
| 165 | regulation of epidermal cell differentiation (GO:0045604) | 2.75240742 |
| 166 | ether lipid metabolic process (GO:0046485) | 2.70508098 |
| 167 | lateral sprouting from an epithelium (GO:0060601) | 2.59964500 |
| 168 | hair follicle development (GO:0001942) | 2.53752231 |
| 169 | alditol phosphate metabolic process (GO:0052646) | 2.53431021 |
| 170 | ethanol metabolic process (GO:0006067) | 2.51876565 |
| 171 | adhesion of symbiont to host (GO:0044406) | 2.51713606 |
| 172 | detection of bacterium (GO:0016045) | 2.51020503 |
| 173 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.47277578 |
| 174 | regulation of keratinocyte proliferation (GO:0010837) | 2.40630353 |
| 175 | phosphatidic acid biosynthetic process (GO:0006654) | 2.36191011 |
| 176 | phosphatidic acid metabolic process (GO:0046473) | 2.36191011 |
| 177 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.36117998 |
| 178 | polarized epithelial cell differentiation (GO:0030859) | 2.36016511 |
| 179 | regulation of glucocorticoid metabolic process (GO:0031943) | 2.31509367 |
| 180 | regulation of epidermis development (GO:0045682) | 2.26215673 |
| 181 | detection of other organism (GO:0098543) | 2.21989674 |
| 182 | sphingoid metabolic process (GO:0046519) | 2.18995157 |
| 183 | lipid storage (GO:0019915) | 2.17295607 |
| 184 | triglyceride metabolic process (GO:0006641) | 2.13664658 |
| 185 | response to fungus (GO:0009620) | 2.11743194 |
| 186 | establishment of planar polarity (GO:0001736) | 2.09008486 |
| 187 | establishment of tissue polarity (GO:0007164) | 2.09008486 |
| 188 | diol metabolic process (GO:0034311) | 2.06768196 |
| 189 | ectoderm development (GO:0007398) | 2.00588734 |
| 190 | fatty acid elongation (GO:0030497) | 15.4718135 |
| 191 | intermediate filament organization (GO:0045109) | 13.2578366 |
| 192 | keratinization (GO:0031424) | 10.8577437 |
| 193 | establishment of skin barrier (GO:0061436) | 10.7553650 |
| 194 | desmosome organization (GO:0002934) | 10.0508023 |
| 195 | monocarboxylic acid biosynthetic process (GO:0072330) | 1.97474576 |
| 196 | phosphatidylglycerol metabolic process (GO:0046471) | 1.96562870 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 9.72285083 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.31631064 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.12492613 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.96312121 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.43602925 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.12558724 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.92837321 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.84822052 |
| 9 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 4.51876813 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.04118259 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.90983094 |
| 12 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 3.59617170 |
| 13 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.10910639 |
| 14 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 2.43494042 |
| 15 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.07344978 |
| 16 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.05908993 |
| 17 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.6961362 |
| 18 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 10.8984861 |
| 19 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.97429910 |
| 20 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.79020324 |
| 21 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.74777258 |
| 22 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.73817927 |
| 23 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.60863291 |
| 24 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.56506162 |
| 25 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.54480824 |
| 26 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.52559345 |
| 27 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.52143982 |
| 28 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.52143982 |
| 29 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 1.48716240 |
| 30 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.45915167 |
| 31 | RXR_22108803_ChIP-Seq_LS180_Human | 1.45680128 |
| 32 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.43683903 |
| 33 | * CTCF_20526341_ChIP-Seq_ESCs_Human | 1.41428664 |
| 34 | * GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.37521136 |
| 35 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.36682401 |
| 36 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.36617657 |
| 37 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.35418529 |
| 38 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.35081115 |
| 39 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.30014657 |
| 40 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.29888398 |
| 41 | GATA1_22025678_ChIP-Seq_K562_Human | 1.28209387 |
| 42 | * GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.27383971 |
| 43 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.23932811 |
| 44 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.23050573 |
| 45 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.21673193 |
| 46 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.17562946 |
| 47 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.13512859 |
| 48 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.11994151 |
| 49 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.11654050 |
| 50 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.11054068 |
| 51 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.09120499 |
| 52 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.07994051 |
| 53 | P68_20966046_ChIP-Seq_HELA_Human | 1.06983261 |
| 54 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.04245931 |
| 55 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.03999719 |
| 56 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.03503028 |
| 57 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.99741639 |
| 58 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.98182634 |
| 59 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.96763181 |
| 60 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.96728128 |
| 61 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.96658247 |
| 62 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.96463481 |
| 63 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.96463481 |
| 64 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.95710648 |
| 65 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94824944 |
| 66 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.94717259 |
| 67 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.93686020 |
| 68 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.93284834 |
| 69 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.93174788 |
| 70 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.92926557 |
| 71 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.91803146 |
| 72 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.91694422 |
| 73 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.91408891 |
| 74 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.91247961 |
| 75 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.90948606 |
| 76 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.90426959 |
| 77 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.89830410 |
| 78 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87941602 |
| 79 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.87810040 |
| 80 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.86506560 |
| 81 | * HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.85712696 |
| 82 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.85078453 |
| 83 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.83509504 |
| 84 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.82865415 |
| 85 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.82220715 |
| 86 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.81645363 |
| 87 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.81207492 |
| 88 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.80874225 |
| 89 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.79706594 |
| 90 | * PHF8_20622853_ChIP-Seq_HELA_Human | 0.77757965 |
| 91 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.77492108 |
| 92 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.77284409 |
| 93 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.77132454 |
| 94 | TBL1_22424771_ChIP-Seq_293T_Human | 0.76993815 |
| 95 | P300_27268052_Chip-Seq_Bcells_Human | 0.75928157 |
| 96 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.75685376 |
| 97 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.73365007 |
| 98 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.72961407 |
| 99 | * RBPJ_21746931_ChIP-Seq_IB4_Human | 0.72791240 |
| 100 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.72543793 |
| 101 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.72329522 |
| 102 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.71430353 |
| 103 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.71405497 |
| 104 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.71405497 |
| 105 | NFYB_21822215_ChIP-Seq_K562_Human | 0.71000500 |
| 106 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.70840395 |
| 107 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.70787071 |
| 108 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.70345151 |
| 109 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.70277714 |
| 110 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.70036165 |
| 111 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.69596933 |
| 112 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.69467064 |
| 113 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.69216790 |
| 114 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.68728250 |
| 115 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.67860931 |
| 116 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.67860931 |
| 117 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.67366342 |
| 118 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.66315375 |
| 119 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.66284643 |
| 120 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.66044094 |
| 121 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.65985441 |
| 122 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.65821000 |
| 123 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.64578341 |
| 124 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.61311673 |
| 125 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.59812303 |
| 126 | AR_20517297_ChIP-Seq_VCAP_Human | 0.57807382 |
| 127 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.57751603 |
| 128 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.57367965 |
| 129 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.57191822 |
| 130 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.56575714 |
| 131 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.56466465 |
| 132 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.55539221 |
| 133 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.54263805 |
| 134 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.54134598 |
| 135 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.53901144 |
| 136 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.53573526 |
| 137 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.53219328 |
| 138 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.52501467 |
| 139 | CBP_21632823_ChIP-Seq_H3396_Human | 0.52437532 |
| 140 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.52198634 |
| 141 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.50281363 |
| 142 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.50224815 |
| 143 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.48290985 |
| 144 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.46880131 |
| 145 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.46432738 |
| 146 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.45882710 |
| 147 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.45453874 |
| 148 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.45264686 |
| 149 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.43839591 |
| 150 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.43743692 |
| 151 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 0.42971100 |
| 152 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.42682338 |
| 153 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.42364022 |
| 154 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.41711817 |
| 155 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.41205221 |
| 156 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.40338095 |
| 157 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.39917121 |
| 158 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.39692230 |
| 159 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.39428026 |
| 160 | GATA2_19941826_ChIP-Seq_K562_Human | 0.38954198 |
| 161 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.38660422 |
| 162 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.38610872 |
| 163 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.38436646 |
| 164 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.38034761 |
| 165 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.37507090 |
| 166 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.37219986 |
| 167 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.36947479 |
| 168 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.36693959 |
| 169 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.36522285 |
| 170 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.36450088 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.37310041 |
| 2 | MP0005360_urolithiasis | 7.82001245 |
| 3 | MP0000647_abnormal_sebaceous_gland | 6.42705295 |
| 4 | MP0005275_abnormal_skin_tensile | 6.28488828 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 6.27585326 |
| 6 | MP0005365_abnormal_bile_salt | 6.05765549 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 5.05188476 |
| 8 | MP0002098_abnormal_vibrissa_morphology | 5.03304512 |
| 9 | MP0009379_abnormal_foot_pigmentation | 4.80676123 |
| 10 | MP0010234_abnormal_vibrissa_follicle | 4.63701112 |
| 11 | MP0003806_abnormal_nucleotide_metabolis | 4.26966391 |
| 12 | MP0003252_abnormal_bile_duct | 3.86494680 |
| 13 | MP0005501_abnormal_skin_physiology | 3.74880187 |
| 14 | MP0001188_hyperpigmentation | 3.58037774 |
| 15 | MP0005075_abnormal_melanosome_morpholog | 3.56229814 |
| 16 | MP0010329_abnormal_lipoprotein_level | 3.48667260 |
| 17 | MP0000377_abnormal_hair_follicle | 3.45684610 |
| 18 | MP0009840_abnormal_foam_cell | 3.13988933 |
| 19 | MP0005083_abnormal_biliary_tract | 2.97289799 |
| 20 | MP0005332_abnormal_amino_acid | 2.97116949 |
| 21 | MP0003195_calcinosis | 2.96363868 |
| 22 | MP0004947_skin_inflammation | 2.83535543 |
| 23 | MP0003453_abnormal_keratinocyte_physiol | 2.67272550 |
| 24 | MP0001666_abnormal_nutrient_absorption | 2.63744307 |
| 25 | MP0001216_abnormal_epidermal_layer | 2.61665941 |
| 26 | MP0010678_abnormal_skin_adnexa | 2.55724769 |
| 27 | MP0002060_abnormal_skin_morphology | 2.49882755 |
| 28 | MP0004019_abnormal_vitamin_homeostasis | 2.43998094 |
| 29 | MP0000383_abnormal_hair_follicle | 2.42220111 |
| 30 | MP0002095_abnormal_skin_pigmentation | 2.34055979 |
| 31 | MP0010771_integument_phenotype | 2.29998154 |
| 32 | MP0003191_abnormal_cellular_cholesterol | 2.16462815 |
| 33 | MP0002138_abnormal_hepatobiliary_system | 2.08572493 |
| 34 | MP0000609_abnormal_liver_physiology | 2.07520626 |
| 35 | MP0002118_abnormal_lipid_homeostasis | 2.05990080 |
| 36 | MP0000367_abnormal_coat/_hair | 1.93723732 |
| 37 | MP0003300_gastrointestinal_ulcer | 1.86582633 |
| 38 | MP0001243_abnormal_dermal_layer | 1.85939309 |
| 39 | MP0005319_abnormal_enzyme/_coenzyme | 1.83062120 |
| 40 | MP0000427_abnormal_hair_cycle | 1.80908711 |
| 41 | MP0003868_abnormal_feces_composition | 1.78130371 |
| 42 | MP0003878_abnormal_ear_physiology | 1.71054161 |
| 43 | MP0005377_hearing/vestibular/ear_phenot | 1.71054161 |
| 44 | MP0005409_darkened_coat_color | 1.66586863 |
| 45 | MP0001764_abnormal_homeostasis | 1.64804955 |
| 46 | MP0005451_abnormal_body_composition | 1.62523479 |
| 47 | MP0009697_abnormal_copulation | 1.62247085 |
| 48 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.58376400 |
| 49 | MP0000566_synostosis | 1.55322366 |
| 50 | MP0009931_abnormal_skin_appearance | 1.52306615 |
| 51 | MP0000015_abnormal_ear_pigmentation | 1.42357535 |
| 52 | MP0009643_abnormal_urine_homeostasis | 1.41919088 |
| 53 | MP0003186_abnormal_redox_activity | 1.36508195 |
| 54 | MP0004885_abnormal_endolymph | 1.34635438 |
| 55 | MP0003011_delayed_dark_adaptation | 1.31609877 |
| 56 | MP0005174_abnormal_tail_pigmentation | 1.29990556 |
| 57 | MP0005647_abnormal_sex_gland | 1.15310674 |
| 58 | MP0009764_decreased_sensitivity_to | 1.12715884 |
| 59 | MP0000598_abnormal_liver_morphology | 1.10425917 |
| 60 | MP0001191_abnormal_skin_condition | 1.09250285 |
| 61 | MP0003705_abnormal_hypodermis_morpholog | 1.08355982 |
| 62 | MP0003656_abnormal_erythrocyte_physiolo | 1.06931184 |
| 63 | MP0003941_abnormal_skin_development | 1.06700411 |
| 64 | MP0005636_abnormal_mineral_homeostasis | 1.05401349 |
| 65 | MP0000467_abnormal_esophagus_morphology | 1.00753304 |
| 66 | MP0002254_reproductive_system_inflammat | 0.98475027 |
| 67 | MP0009763_increased_sensitivity_to | 0.97432552 |
| 68 | MP0000604_amyloidosis | 0.97402752 |
| 69 | MP0002876_abnormal_thyroid_physiology | 0.92793177 |
| 70 | MP0010368_abnormal_lymphatic_system | 0.89888419 |
| 71 | MP0005084_abnormal_gallbladder_morpholo | 0.87585135 |
| 72 | MP0009642_abnormal_blood_homeostasis | 0.87444600 |
| 73 | MP0008469_abnormal_protein_level | 0.87383476 |
| 74 | MP0006036_abnormal_mitochondrial_physio | 0.86178461 |
| 75 | MP0009780_abnormal_chondrocyte_physiolo | 0.84135646 |
| 76 | MP0005408_hypopigmentation | 0.80902357 |
| 77 | MP0005670_abnormal_white_adipose | 0.80848431 |
| 78 | MP0003763_abnormal_thymus_physiology | 0.80829622 |
| 79 | MP0002078_abnormal_glucose_homeostasis | 0.76043153 |
| 80 | MP0009765_abnormal_xenobiotic_induced | 0.75782824 |
| 81 | MP0005376_homeostasis/metabolism_phenot | 0.75082804 |
| 82 | MP0001661_extended_life_span | 0.73482638 |
| 83 | MP0005220_abnormal_exocrine_pancreas | 0.71645542 |
| 84 | MP0001756_abnormal_urination | 0.71372546 |
| 85 | MP0002971_abnormal_brown_adipose | 0.70548549 |
| 86 | MP0005535_abnormal_body_temperature | 0.68741263 |
| 87 | MP0005334_abnormal_fat_pad | 0.67914848 |
| 88 | MP0001984_abnormal_olfaction | 0.64690545 |
| 89 | MP0005266_abnormal_metabolism | 0.62984548 |
| 90 | MP0009053_abnormal_anal_canal | 0.62680107 |
| 91 | MP0002136_abnormal_kidney_physiology | 0.62286312 |
| 92 | MP0004130_abnormal_muscle_cell | 0.61535220 |
| 93 | MP0003690_abnormal_glial_cell | 0.61515546 |
| 94 | MP0001851_eye_inflammation | 0.61434706 |
| 95 | MP0006035_abnormal_mitochondrial_morpho | 0.57356636 |
| 96 | MP0001784_abnormal_fluid_regulation | 0.56403972 |
| 97 | MP0005448_abnormal_energy_balance | 0.55836085 |
| 98 | MP0004782_abnormal_surfactant_physiolog | 0.54413612 |
| 99 | MP0010030_abnormal_orbit_morphology | 0.54009929 |
| 100 | MP0003329_amyloid_beta_deposits | 0.53626598 |
| 101 | MP0004043_abnormal_pH_regulation | 0.52607759 |
| 102 | MP0002009_preneoplasia | 0.52167534 |
| 103 | MP0005395_other_phenotype | 0.52022070 |
| 104 | MP0000639_abnormal_adrenal_gland | 0.51109124 |
| 105 | MP0002928_abnormal_bile_duct | 0.49223470 |
| 106 | MP0003638_abnormal_response/metabolism_ | 0.48975602 |
| 107 | MP0003718_maternal_effect | 0.48376944 |
| 108 | MP0000762_abnormal_tongue_morphology | 0.48299382 |
| 109 | MP0000465_gastrointestinal_hemorrhage | 0.47421234 |
| 110 | MP0004858_abnormal_nervous_system | 0.47057599 |
| 111 | MP0002282_abnormal_trachea_morphology | 0.46746872 |
| 112 | MP0005503_abnormal_tendon_morphology | 0.45911331 |
| 113 | MP0005248_abnormal_Harderian_gland | 0.44539157 |
| 114 | MP0002822_catalepsy | 0.44273428 |
| 115 | MP0003724_increased_susceptibility_to | 0.44027320 |
| 116 | MP0005464_abnormal_platelet_physiology | 0.43910732 |
| 117 | MP0003566_abnormal_cell_adhesion | 0.43616888 |
| 118 | MP0003953_abnormal_hormone_level | 0.43314320 |
| 119 | MP0002837_dystrophic_cardiac_calcinosis | 0.42570496 |
| 120 | MP0008874_decreased_physiological_sensi | 0.40871906 |
| 121 | MP0005666_abnormal_adipose_tissue | 0.39323123 |
| 122 | MP0000579_abnormal_nail_morphology | 0.37454430 |
| 123 | MP0008873_increased_physiological_sensi | 0.36984284 |
| 124 | MP0002168_other_aberrant_phenotype | 0.36628607 |
| 125 | MP0005166_decreased_susceptibility_to | 0.36527743 |
| 126 | MP0006082_CNS_inflammation | 0.36504213 |
| 127 | MP0003436_decreased_susceptibility_to | 0.35890945 |
| 128 | MP0003075_altered_response_to | 0.35484661 |
| 129 | MP0000230_abnormal_systemic_arterial | 0.35442401 |
| 130 | MP0009672_abnormal_birth_weight | 0.34853694 |
| 131 | MP0008872_abnormal_physiological_respon | 0.34374382 |
| 132 | MP0002166_altered_tumor_susceptibility | 0.34339363 |
| 133 | MP0001765_abnormal_ion_homeostasis | 0.34176510 |
| 134 | MP0002177_abnormal_outer_ear | 0.33902657 |
| 135 | MP0002796_impaired_skin_barrier | 0.33314579 |
| 136 | MP0009115_abnormal_fat_cell | 0.32360787 |
| 137 | MP0000685_abnormal_immune_system | 0.30944809 |
| 138 | MP0004381_abnormal_hair_follicle | 0.30671700 |
| 139 | MP0001853_heart_inflammation | 0.28963480 |
| 140 | MP0002132_abnormal_respiratory_system | 0.28701530 |
| 141 | MP0001845_abnormal_inflammatory_respons | 0.28418071 |
| 142 | MP0000249_abnormal_blood_vessel | 0.28214384 |
| 143 | MP0001186_pigmentation_phenotype | 0.26754443 |
| 144 | MP0002970_abnormal_white_adipose | 0.26433965 |
| 145 | MP0005058_abnormal_lysosome_morphology | 0.26152344 |
| 146 | MP0009384_cardiac_valve_regurgitation | 0.26019865 |
| 147 | MP0001919_abnormal_reproductive_system | 0.26007272 |
| 148 | MP0002135_abnormal_kidney_morphology | 0.25889812 |
| 149 | MP0000538_abnormal_urinary_bladder | 0.25446003 |
| 150 | MP0001485_abnormal_pinna_reflex | 0.24611479 |
| 151 | MP0004264_abnormal_extraembryonic_tissu | 0.24573480 |
| 152 | MP0002148_abnormal_hypersensitivity_rea | 0.22915630 |
| 153 | MP0000372_irregular_coat_pigmentation | 0.22680811 |
| 154 | MP0000627_abnormal_mammary_gland | 0.21803837 |
| 155 | MP0000462_abnormal_digestive_system | 0.20595690 |
| 156 | MP0002006_tumorigenesis | 0.19788756 |
| 157 | MP0005671_abnormal_response_to | 0.18195820 |
| 158 | MP0001340_abnormal_eyelid_morphology | 0.17099376 |
| 159 | MP0002163_abnormal_gland_morphology | 0.16131038 |
| 160 | MP0005023_abnormal_wound_healing | 0.15831309 |
| 161 | MP0002249_abnormal_larynx_morphology | 0.15615902 |
| 162 | MP0005646_abnormal_pituitary_gland | 0.15315170 |
| 163 | MP0004185_abnormal_adipocyte_glucose | 0.14785482 |
| 164 | MP0009333_abnormal_splenocyte_physiolog | 0.13519532 |
| 165 | MP0001958_emphysema | 0.13239158 |
| 166 | MP0002877_abnormal_melanocyte_morpholog | 0.12986365 |
| 167 | MP0001849_ear_inflammation | 0.12026474 |
| 168 | MP0002111_abnormal_tail_morphology | 0.11951652 |
| 169 | MP0008004_abnormal_stomach_pH | 0.11686790 |
| 170 | MP0005508_abnormal_skeleton_morphology | 0.09552596 |
| 171 | MP0010386_abnormal_urinary_bladder | 0.08946790 |
| 172 | MP0010352_gastrointestinal_tract_polyps | 0.08538153 |
| 173 | MP0004742_abnormal_vestibular_system | 0.07948937 |
| 174 | MP0000751_myopathy | 0.06373443 |
| 175 | MP0005452_abnormal_adipose_tissue | 0.04440428 |
| 176 | MP0003045_fibrosis | 0.03606020 |
| 177 | MP0000516_abnormal_urinary_system | 0.02612889 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased IgE level (HP:0003212) | 9.73241255 |
| 2 | Woolly hair (HP:0002224) | 9.49438596 |
| 3 | Hypotrichosis (HP:0001006) | 9.35819746 |
| 4 | Onycholysis (HP:0001806) | 9.22196412 |
| 5 | Abnormal hair laboratory examination (HP:0003328) | 7.60988939 |
| 6 | Abnormality of hair growth rate (HP:0011363) | 7.40710559 |
| 7 | Slow-growing hair (HP:0002217) | 7.40710559 |
| 8 | Brittle hair (HP:0002299) | 7.20017301 |
| 9 | Intrahepatic cholestasis (HP:0001406) | 7.17446056 |
| 10 | Palmoplantar hyperkeratosis (HP:0000972) | 7.16528500 |
| 11 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.15951450 |
| 12 | Conjunctival hamartoma (HP:0100780) | 7.03354698 |
| 13 | Deep venous thrombosis (HP:0002625) | 7.02154577 |
| 14 | Erythroderma (HP:0001019) | 6.93651261 |
| 15 | Palmar hyperkeratosis (HP:0010765) | 6.80428997 |
| 16 | Erythema (HP:0010783) | 6.43461739 |
| 17 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.41273278 |
| 18 | Prolonged partial thromboplastin time (HP:0003645) | 6.24942827 |
| 19 | Hypobetalipoproteinemia (HP:0003563) | 6.16038055 |
| 20 | Xanthomatosis (HP:0000991) | 6.04338543 |
| 21 | Plantar hyperkeratosis (HP:0007556) | 5.80233294 |
| 22 | Absent eyelashes (HP:0000561) | 5.35666697 |
| 23 | Abnormality of the axillary hair (HP:0100134) | 5.32342932 |
| 24 | Abnormality of secondary sexual hair (HP:0009888) | 5.32342932 |
| 25 | Hyperlipoproteinemia (HP:0010980) | 5.30692991 |
| 26 | Abnormality of nail color (HP:0100643) | 5.13257650 |
| 27 | Alopecia of scalp (HP:0002293) | 4.93618261 |
| 28 | Complement deficiency (HP:0004431) | 4.90464092 |
| 29 | Congenital ichthyosiform erythroderma (HP:0007431) | 4.80997293 |
| 30 | Hamartoma of the eye (HP:0010568) | 4.78458835 |
| 31 | Dry hair (HP:0011359) | 4.73377577 |
| 32 | Joint hemorrhage (HP:0005261) | 4.72488690 |
| 33 | Hyperglycinemia (HP:0002154) | 4.70928958 |
| 34 | Hyperammonemia (HP:0001987) | 4.70546152 |
| 35 | Hypolipoproteinemia (HP:0010981) | 4.59925049 |
| 36 | Thick nail (HP:0001805) | 4.53094647 |
| 37 | Hyperglycinuria (HP:0003108) | 4.49105398 |
| 38 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.48113130 |
| 39 | Ketosis (HP:0001946) | 4.40218244 |
| 40 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.33206363 |
| 41 | Abnormality of glycine metabolism (HP:0010895) | 4.33206363 |
| 42 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.27815590 |
| 43 | Epidermoid cyst (HP:0200040) | 4.26413588 |
| 44 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 4.21313507 |
| 45 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.18949099 |
| 46 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.18228185 |
| 47 | Abnormality of the common coagulation pathway (HP:0010990) | 4.17256940 |
| 48 | Fat malabsorption (HP:0002630) | 4.13576148 |
| 49 | Nail dystrophy (HP:0008404) | 4.07924922 |
| 50 | Absent hair (HP:0002298) | 4.07005463 |
| 51 | Abnormality of methionine metabolism (HP:0010901) | 4.02813965 |
| 52 | Hypoalphalipoproteinemia (HP:0003233) | 3.97983251 |
| 53 | Hypoglycemic coma (HP:0001325) | 3.97359102 |
| 54 | Absent eyebrow (HP:0002223) | 3.86347021 |
| 55 | Conjugated hyperbilirubinemia (HP:0002908) | 3.81352501 |
| 56 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.79643885 |
| 57 | Sparse eyelashes (HP:0000653) | 3.72405450 |
| 58 | Fine hair (HP:0002213) | 3.60798181 |
| 59 | Abnormality of the intrinsic pathway (HP:0010989) | 3.59608113 |
| 60 | Abnormality of complement system (HP:0005339) | 3.55988355 |
| 61 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.55548917 |
| 62 | Hypercholesterolemia (HP:0003124) | 3.46591909 |
| 63 | Delayed CNS myelination (HP:0002188) | 3.35153624 |
| 64 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.33728057 |
| 65 | Ketoacidosis (HP:0001993) | 3.33677928 |
| 66 | Abnormal blistering of the skin (HP:0008066) | 3.30991552 |
| 67 | Hyperbilirubinemia (HP:0002904) | 3.30592808 |
| 68 | Abnormality of nucleobase metabolism (HP:0010932) | 3.28061217 |
| 69 | Abnormality of serum amino acid levels (HP:0003112) | 3.18676152 |
| 70 | Follicular hyperkeratosis (HP:0007502) | 3.18138675 |
| 71 | Steatorrhea (HP:0002570) | 3.10028713 |
| 72 | Right ventricular cardiomyopathy (HP:0011663) | 3.02731738 |
| 73 | Abnormality of purine metabolism (HP:0004352) | 3.02269883 |
| 74 | Palmoplantar keratoderma (HP:0000982) | 3.01907074 |
| 75 | Corneal erosion (HP:0200020) | 2.98783926 |
| 76 | Hepatocellular carcinoma (HP:0001402) | 2.94631265 |
| 77 | Fragile nails (HP:0001808) | 2.94196307 |
| 78 | Metabolic acidosis (HP:0001942) | 2.93470471 |
| 79 | Vascular calcification (HP:0004934) | 2.90993392 |
| 80 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.88691976 |
| 81 | Dicarboxylic aciduria (HP:0003215) | 2.88691976 |
| 82 | Gout (HP:0001997) | 2.87186552 |
| 83 | Myocardial infarction (HP:0001658) | 2.86648375 |
| 84 | Hypochromic microcytic anemia (HP:0004840) | 2.81154146 |
| 85 | Spontaneous abortion (HP:0005268) | 2.75070037 |
| 86 | Lethargy (HP:0001254) | 2.74279517 |
| 87 | Sparse scalp hair (HP:0002209) | 2.66265503 |
| 88 | Parakeratosis (HP:0001036) | 2.64976847 |
| 89 | Hypergammaglobulinemia (HP:0010702) | 2.59511445 |
| 90 | Cardiovascular calcification (HP:0011915) | 2.57308044 |
| 91 | Systemic lupus erythematosus (HP:0002725) | 2.57096484 |
| 92 | Gangrene (HP:0100758) | 2.55242541 |
| 93 | Generalized aminoaciduria (HP:0002909) | 2.54214916 |
| 94 | Hypoglycemic seizures (HP:0002173) | 2.53534730 |
| 95 | Malnutrition (HP:0004395) | 2.53495658 |
| 96 | Skin nodule (HP:0200036) | 2.53437572 |
| 97 | Congenital, generalized hypertrichosis (HP:0004540) | 2.49852702 |
| 98 | Abnormality of the pupil (HP:0000615) | 2.48989757 |
| 99 | Cerebral edema (HP:0002181) | 2.39546685 |
| 100 | Ridged nail (HP:0001807) | 2.39407921 |
| 101 | Spastic diplegia (HP:0001264) | 2.38909878 |
| 102 | Acanthocytosis (HP:0001927) | 2.37681260 |
| 103 | Glomerulonephritis (HP:0000099) | 2.37547097 |
| 104 | Hypohidrosis (HP:0000966) | 2.37452316 |
| 105 | Irritability (HP:0000737) | 2.37221916 |
| 106 | Hamartoma (HP:0010566) | 2.32219233 |
| 107 | Proximal tubulopathy (HP:0000114) | 2.30289513 |
| 108 | Neonatal onset (HP:0003623) | 2.29612660 |
| 109 | Abnormal gallbladder morphology (HP:0012437) | 2.29131371 |
| 110 | Enlarged kidneys (HP:0000105) | 2.27650426 |
| 111 | Mitral stenosis (HP:0001718) | 2.25912973 |
| 112 | Cholelithiasis (HP:0001081) | 2.24452400 |
| 113 | Abnormality of proline metabolism (HP:0010907) | 2.24088005 |
| 114 | Hydroxyprolinuria (HP:0003080) | 2.24088005 |
| 115 | Sensorimotor neuropathy (HP:0007141) | 2.23933069 |
| 116 | Vomiting (HP:0002013) | 2.23800834 |
| 117 | Late onset (HP:0003584) | 2.23462542 |
| 118 | Pancreatitis (HP:0001733) | 2.22630458 |
| 119 | Blepharitis (HP:0000498) | 2.21575629 |
| 120 | Milia (HP:0001056) | 2.20409080 |
| 121 | Esophageal varix (HP:0002040) | 2.18191399 |
| 122 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.15850043 |
| 123 | Rickets (HP:0002748) | 2.14569819 |
| 124 | Abnormal gallbladder physiology (HP:0012438) | 2.13802676 |
| 125 | Cholecystitis (HP:0001082) | 2.13802676 |
| 126 | Alkalosis (HP:0001948) | 2.12015029 |
| 127 | Melanocytic nevus (HP:0000995) | 2.11996833 |
| 128 | Opisthotonus (HP:0002179) | 2.10383945 |
| 129 | Renal cortical cysts (HP:0000803) | 2.08469984 |
| 130 | Menorrhagia (HP:0000132) | 2.06937010 |
| 131 | Glycosuria (HP:0003076) | 2.05567008 |
| 132 | Abnormality of urine glucose concentration (HP:0011016) | 2.05567008 |
| 133 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.05326041 |
| 134 | Amyloidosis (HP:0011034) | 2.04417024 |
| 135 | Gingival bleeding (HP:0000225) | 2.03405199 |
| 136 | Brushfield spots (HP:0001088) | 2.03339056 |
| 137 | Abnormality of the salivary glands (HP:0010286) | 2.03190057 |
| 138 | Hyperuricemia (HP:0002149) | 2.02752459 |
| 139 | Increased purine levels (HP:0004368) | 2.02752459 |
| 140 | Acanthosis nigricans (HP:0000956) | 2.02058659 |
| 141 | Thrombophlebitis (HP:0004418) | 2.00315149 |
| 142 | Pili torti (HP:0003777) | 10.9907790 |
| 143 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.99504730 |
| 144 | Hypophosphatemic rickets (HP:0004912) | 1.98434216 |
| 145 | Coarse hair (HP:0002208) | 1.92212575 |
| 146 | Abnormality of the gallbladder (HP:0005264) | 1.90541610 |
| 147 | Hemorrhage of the eye (HP:0011885) | 1.90414069 |
| 148 | Pruritus (HP:0000989) | 1.89571215 |
| 149 | Poikilocytosis (HP:0004447) | 1.88242553 |
| 150 | Abnormality of the dental root (HP:0006486) | 1.84807921 |
| 151 | Taurodontia (HP:0000679) | 1.84807921 |
| 152 | Abnormality of permanent molar morphology (HP:0011071) | 1.84807921 |
| 153 | Abnormality of vitamin metabolism (HP:0100508) | 1.84590521 |
| 154 | Elevated hepatic transaminases (HP:0002910) | 1.83304095 |
| 155 | Status epilepticus (HP:0002133) | 1.81382883 |
| 156 | Urticaria (HP:0001025) | 1.77300950 |
| 157 | Conical tooth (HP:0000698) | 1.75458247 |
| 158 | Abnormality of molar morphology (HP:0011070) | 1.75134448 |
| 159 | Abnormality of molar (HP:0011077) | 1.75134448 |
| 160 | Advanced eruption of teeth (HP:0006288) | 1.68633530 |
| 161 | Septate vagina (HP:0001153) | 1.67625805 |
| 162 | Abnormality of the dental pulp (HP:0006479) | 1.66132295 |
| 163 | Split foot (HP:0001839) | 1.64254915 |
| 164 | Fatigable weakness (HP:0003473) | 1.64199577 |
| 165 | Abnormality of the neuromuscular junction (HP:0003398) | 1.64199577 |
| 166 | Oral leukoplakia (HP:0002745) | 1.64154098 |
| 167 | Papilloma (HP:0012740) | 1.61195026 |
| 168 | Verrucae (HP:0200043) | 1.61195026 |
| 169 | Skin ulcer (HP:0200042) | 1.56042387 |
| 170 | Natal tooth (HP:0000695) | 1.54206578 |
| 171 | Furrowed tongue (HP:0000221) | 1.53502792 |
| 172 | Xerostomia (HP:0000217) | 1.52915853 |
| 173 | Nasolacrimal duct obstruction (HP:0000579) | 1.50213188 |
| 174 | Hyperhidrosis (HP:0000975) | 1.49907865 |
| 175 | Lip pit (HP:0100267) | 1.40675226 |
| 176 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.39339778 |
| 177 | Aplasia of the phalanges of the hand (HP:0009802) | 1.39339778 |
| 178 | Aplasia involving bones of the extremities (HP:0009825) | 1.39339778 |
| 179 | Hypoplastic labia majora (HP:0000059) | 1.35837323 |
| 180 | Ventricular tachycardia (HP:0004756) | 1.34113145 |
| 181 | Oligodontia (HP:0000677) | 1.30813169 |
| 182 | Abnormality of the labia majora (HP:0012881) | 1.22873882 |
| 183 | Eczematoid dermatitis (HP:0000976) | 1.22778609 |
| 184 | Ectropion (HP:0000656) | 1.19946408 |
| 185 | Multifactorial inheritance (HP:0001426) | 1.19419687 |
| 186 | Selective tooth agenesis (HP:0001592) | 1.19352894 |
| 187 | Dry skin (HP:0000958) | 1.18313416 |
| 188 | Duplicated collecting system (HP:0000081) | 1.17123749 |
| 189 | Neonatal short-limb short stature (HP:0008921) | 1.15293822 |
| 190 | Seborrheic dermatitis (HP:0001051) | 1.14314332 |
| 191 | Dehydration (HP:0001944) | 1.13299829 |
| 192 | Neonatal death (HP:0003811) | 1.12983320 |
| 193 | Craniofacial hyperostosis (HP:0004493) | 1.10506831 |
| 194 | Generalized hyperpigmentation (HP:0007440) | 1.10203039 |
| 195 | Abnormality of the fingernails (HP:0001231) | 1.09407184 |
| 196 | Abnormality of the lacrimal duct (HP:0011481) | 1.09089211 |
| 197 | Breast hypoplasia (HP:0003187) | 1.02234725 |
| 198 | Ureteral duplication (HP:0000073) | 0.98055867 |
| 199 | Depressed nasal tip (HP:0000437) | 0.97926022 |
| 200 | Abnormality of the renal collecting system (HP:0004742) | 0.97910923 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.36134079 |
| 2 | MAPKAPK3 | 5.63390539 |
| 3 | TGFBR1 | 5.08116915 |
| 4 | EEF2K | 5.03810347 |
| 5 | SIK1 | 4.53028552 |
| 6 | FGFR4 | 4.39506412 |
| 7 | ERN1 | 4.12857349 |
| 8 | INSRR | 3.16797537 |
| 9 | FER | 2.91192586 |
| 10 | TAOK3 | 2.86592927 |
| 11 | ERBB4 | 2.57771227 |
| 12 | RPS6KB2 | 2.42602845 |
| 13 | STK24 | 2.28850958 |
| 14 | MST1R | 2.28577743 |
| 15 | TRPM7 | 2.11947651 |
| 16 | PIK3CG | 1.99119254 |
| 17 | PRPF4B | 1.98963637 |
| 18 | MAP2K4 | 1.98375368 |
| 19 | MAPKAPK5 | 1.94995696 |
| 20 | LATS1 | 1.93665467 |
| 21 | FLT3 | 1.86950000 |
| 22 | PKN2 | 1.83476456 |
| 23 | PINK1 | 1.76356259 |
| 24 | MYLK | 1.75614536 |
| 25 | MAPK11 | 1.73700149 |
| 26 | STK39 | 1.66752946 |
| 27 | STK38L | 1.66010284 |
| 28 | DAPK2 | 1.61643424 |
| 29 | FGFR1 | 1.59939578 |
| 30 | TYK2 | 1.59310642 |
| 31 | FRK | 1.55698551 |
| 32 | NLK | 1.45002986 |
| 33 | ABL2 | 1.36998840 |
| 34 | PTK6 | 1.33982274 |
| 35 | NEK9 | 1.28944558 |
| 36 | TRIB3 | 1.28652096 |
| 37 | MAP3K14 | 1.24520388 |
| 38 | IRAK3 | 1.22104183 |
| 39 | PRKAA2 | 1.21927217 |
| 40 | MAP3K7 | 1.16490468 |
| 41 | MAP3K2 | 1.13091366 |
| 42 | KIT | 1.11573276 |
| 43 | FGFR2 | 1.10363801 |
| 44 | JAK2 | 1.05762431 |
| 45 | KDR | 1.05634643 |
| 46 | GRK6 | 1.04109157 |
| 47 | RPS6KB1 | 1.01261989 |
| 48 | JAK1 | 0.98885219 |
| 49 | LMTK2 | 0.98218648 |
| 50 | MAPKAPK2 | 0.96926259 |
| 51 | EIF2AK3 | 0.92119581 |
| 52 | TBK1 | 0.91793322 |
| 53 | PRKCZ | 0.90081238 |
| 54 | NEK6 | 0.89883512 |
| 55 | MAPK4 | 0.88414389 |
| 56 | TIE1 | 0.88313118 |
| 57 | ERBB2 | 0.85887459 |
| 58 | MAPK7 | 0.85358422 |
| 59 | SGK3 | 0.84203630 |
| 60 | TESK1 | 0.83196077 |
| 61 | IKBKB | 0.82071630 |
| 62 | MAP2K3 | 0.81901393 |
| 63 | LRRK2 | 0.81216911 |
| 64 | MET | 0.79616385 |
| 65 | PRKAA1 | 0.78160059 |
| 66 | MAP3K3 | 0.77927259 |
| 67 | SGK2 | 0.77332285 |
| 68 | MAPK12 | 0.75919426 |
| 69 | PRKACG | 0.75359717 |
| 70 | SMG1 | 0.74787792 |
| 71 | TAOK2 | 0.74153757 |
| 72 | WNK3 | 0.73820359 |
| 73 | MAP3K10 | 0.73653313 |
| 74 | DYRK1B | 0.72341516 |
| 75 | MAP2K6 | 0.71444884 |
| 76 | CDK6 | 0.70633094 |
| 77 | GSK3A | 0.70570346 |
| 78 | MARK2 | 0.70501616 |
| 79 | CSK | 0.70259647 |
| 80 | TAOK1 | 0.69722466 |
| 81 | GRK1 | 0.69632803 |
| 82 | MAPK15 | 0.69450372 |
| 83 | MAP3K13 | 0.69127750 |
| 84 | WNK4 | 0.67844781 |
| 85 | EPHA2 | 0.65320512 |
| 86 | CAMK1D | 0.64825198 |
| 87 | MAP3K11 | 0.64727188 |
| 88 | SGK223 | 0.63269735 |
| 89 | SGK494 | 0.63269735 |
| 90 | PDK4 | 0.62449144 |
| 91 | PDK3 | 0.62449144 |
| 92 | EPHB1 | 0.60237006 |
| 93 | RIPK1 | 0.60189241 |
| 94 | EPHA3 | 0.59112155 |
| 95 | TGFBR2 | 0.58927370 |
| 96 | AKT3 | 0.58626843 |
| 97 | PBK | 0.58590556 |
| 98 | MAP3K1 | 0.58403853 |
| 99 | IKBKE | 0.57457753 |
| 100 | PRKD2 | 0.57410986 |
| 101 | CAMK2G | 0.57212719 |
| 102 | EPHA4 | 0.53861112 |
| 103 | FGFR3 | 0.48299649 |
| 104 | HIPK2 | 0.48150670 |
| 105 | PTK2 | 0.48013692 |
| 106 | ADRBK1 | 0.47656146 |
| 107 | PRKCQ | 0.45501295 |
| 108 | RET | 0.43426997 |
| 109 | ITK | 0.43034547 |
| 110 | IGF1R | 0.42545789 |
| 111 | ICK | 0.42252436 |
| 112 | CSF1R | 0.41236701 |
| 113 | PDPK1 | 0.41219681 |
| 114 | MAP3K12 | 0.40872739 |
| 115 | CDC42BPA | 0.40081639 |
| 116 | PDK2 | 0.37224096 |
| 117 | CDK4 | 0.37150247 |
| 118 | MAP3K5 | 0.36579195 |
| 119 | CAMK4 | 0.36058208 |
| 120 | NUAK1 | 0.35938934 |
| 121 | STK3 | 0.35891009 |
| 122 | PRKD1 | 0.35343761 |
| 123 | EPHB2 | 0.35133677 |
| 124 | CSNK1G1 | 0.34873430 |
| 125 | PHKG2 | 0.34364958 |
| 126 | PHKG1 | 0.34364958 |
| 127 | PRKCG | 0.33746096 |
| 128 | HCK | 0.33098086 |
| 129 | SGK1 | 0.31948614 |
| 130 | MAP2K1 | 0.31693041 |
| 131 | IRAK1 | 0.30836166 |
| 132 | IRAK2 | 0.30407587 |
| 133 | OXSR1 | 0.30396513 |
| 134 | MTOR | 0.28658940 |
| 135 | ILK | 0.28590846 |
| 136 | PRKCA | 0.28126004 |
| 137 | BTK | 0.28080803 |
| 138 | CDK7 | 0.27042791 |
| 139 | MAPK3 | 0.27033892 |
| 140 | MAP3K6 | 0.26998950 |
| 141 | PKN1 | 0.26650636 |
| 142 | JAK3 | 0.26589935 |
| 143 | PRKCE | 0.25791089 |
| 144 | STK38 | 0.25737121 |
| 145 | ADRBK2 | 0.25016008 |
| 146 | CHUK | 0.24700249 |
| 147 | PDK1 | 0.24180878 |
| 148 | EGFR | 0.21630729 |
| 149 | MAP2K2 | 0.20833519 |
| 150 | ACVR1B | 0.20698058 |
| 151 | ABL1 | 0.20608954 |
| 152 | MAPK9 | 0.19083852 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.26248802 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.48922787 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.32037906 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.15056831 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.91263929 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.70876590 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.69748102 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.69179687 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.57011935 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.55098734 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.50487402 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.49683485 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.41114839 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.29128344 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.14572101 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.13501765 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.09494081 |
| 18 | Phototransduction_Homo sapiens_hsa04744 | 1.98379344 |
| 19 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.95550920 |
| 20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.93202573 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.93116997 |
| 22 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.92011272 |
| 23 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.91153470 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.88956596 |
| 25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.84118671 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.81352858 |
| 27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.78823831 |
| 28 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.76858167 |
| 29 | Retinol metabolism_Homo sapiens_hsa00830 | 1.74820674 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.70240552 |
| 31 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.66076591 |
| 32 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.64574235 |
| 33 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.58420620 |
| 34 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.57190196 |
| 35 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.52464595 |
| 36 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.52303635 |
| 37 | Bile secretion_Homo sapiens_hsa04976 | 1.51923292 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.44718190 |
| 39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.39668946 |
| 40 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.38608145 |
| 41 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.38140031 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.35384233 |
| 43 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.33732044 |
| 44 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.24548617 |
| 45 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.22728878 |
| 46 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.21894495 |
| 47 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.18412373 |
| 48 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.18356731 |
| 49 | ABC transporters_Homo sapiens_hsa02010 | 1.17956341 |
| 50 | Carbon metabolism_Homo sapiens_hsa01200 | 1.17844835 |
| 51 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.15565411 |
| 52 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.08633788 |
| 53 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.05258652 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.04703713 |
| 55 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.02271087 |
| 56 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.02037729 |
| 57 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.00443740 |
| 58 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.99816668 |
| 59 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.99465254 |
| 60 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.98489926 |
| 61 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.97035964 |
| 62 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.92282456 |
| 63 | Renin secretion_Homo sapiens_hsa04924 | 0.90459905 |
| 64 | Sulfur relay system_Homo sapiens_hsa04122 | 0.89406741 |
| 65 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.88017489 |
| 66 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.87970773 |
| 67 | Lysine degradation_Homo sapiens_hsa00310 | 0.87626429 |
| 68 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.80567033 |
| 69 | Lysosome_Homo sapiens_hsa04142 | 0.78690982 |
| 70 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.73812641 |
| 71 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.71770318 |
| 72 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.70618089 |
| 73 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.63409482 |
| 74 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.61734359 |
| 75 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.57075998 |
| 76 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.56320107 |
| 77 | Pertussis_Homo sapiens_hsa05133 | 0.53528431 |
| 78 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.52318826 |
| 79 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.51025779 |
| 80 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.50687062 |
| 81 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.49138912 |
| 82 | Metabolic pathways_Homo sapiens_hsa01100 | 0.48759332 |
| 83 | Glioma_Homo sapiens_hsa05214 | 0.48534187 |
| 84 | Salivary secretion_Homo sapiens_hsa04970 | 0.48246430 |
| 85 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.48118095 |
| 86 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.46459792 |
| 87 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.44267493 |
| 88 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.43584762 |
| 89 | Circadian rhythm_Homo sapiens_hsa04710 | 0.39728120 |
| 90 | Long-term potentiation_Homo sapiens_hsa04720 | 0.36985746 |
| 91 | Allograft rejection_Homo sapiens_hsa05330 | 0.35893320 |
| 92 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.35426161 |
| 93 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.35346914 |
| 94 | Tuberculosis_Homo sapiens_hsa05152 | 0.34658952 |
| 95 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.34318427 |
| 96 | Melanogenesis_Homo sapiens_hsa04916 | 0.34244063 |
| 97 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.33951501 |
| 98 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.32888508 |
| 99 | Asthma_Homo sapiens_hsa05310 | 0.32243342 |
| 100 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.31906813 |
| 101 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.30489876 |
| 102 | Olfactory transduction_Homo sapiens_hsa04740 | 0.30174978 |
| 103 | Long-term depression_Homo sapiens_hsa04730 | 0.28826238 |
| 104 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.28748992 |
| 105 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.27933833 |
| 106 | Galactose metabolism_Homo sapiens_hsa00052 | 0.27393363 |
| 107 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.26871148 |
| 108 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.26848529 |
| 109 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.24173173 |
| 110 | Prion diseases_Homo sapiens_hsa05020 | 0.23071285 |
| 111 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.22781800 |
| 112 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.22467229 |
| 113 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.21551787 |
| 114 | Insulin resistance_Homo sapiens_hsa04931 | 0.20100619 |
| 115 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.19360307 |
| 116 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.19050784 |
| 117 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.18896475 |
| 118 | Thyroid cancer_Homo sapiens_hsa05216 | 0.17115273 |
| 119 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.16468715 |
| 120 | Platelet activation_Homo sapiens_hsa04611 | 0.15395094 |
| 121 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.14421754 |
| 122 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.14353109 |
| 123 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.14012746 |
| 124 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.13984299 |
| 125 | Malaria_Homo sapiens_hsa05144 | 0.11749906 |
| 126 | Circadian entrainment_Homo sapiens_hsa04713 | 0.10940063 |
| 127 | Focal adhesion_Homo sapiens_hsa04510 | 0.08832653 |
| 128 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.05485870 |
| 129 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2584366 |
| 130 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2494507 |
| 131 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2392594 |
| 132 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.2174693 |
| 133 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.2009012 |
| 134 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1918560 |
| 135 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1739962 |
| 136 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1729097 |
| 137 | Hepatitis C_Homo sapiens_hsa05160 | -0.1710603 |
| 138 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1704197 |
| 139 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1608763 |
| 140 | Mineral absorption_Homo sapiens_hsa04978 | -0.1577438 |
| 141 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1371492 |
| 142 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1212869 |
| 143 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0977280 |
| 144 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0961904 |
| 145 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0930368 |
| 146 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0692526 |
| 147 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0668214 |
| 148 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0501751 |
| 149 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0370886 |
| 150 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0106149 |

